🔗 Share this article

An underground market for unlicensed weight-loss medications is being driven by social media fitness personalities and vendors on communication apps, based on new investigations.

Investigational Treatment Gaining Traction Via Social Media

Retatrutide, which is still in research studies, is being promoted by social media influencers for its alleged fat-burning effects. Followers are encouraged to message these profiles privately for source information, while also receiving discount codes.

Thriving Commerce on Social Networks

Additionally, a robust trade exists on messaging services, where groups with thousands of members share comparison photos, administration instructions and assertions of next-day UK delivery. Sellers promote the drug there before redirecting customers to other platforms for transactions.

Learning About Retatrutide

Retatrutide is an experimental injection created by US drugmaker Eli Lilly. The drug targets three intestinal hormones – GLP-1, GIP and glucagon. Preliminary studies suggest it could assist patients lose up to a quarter of their total weight. Nicknamed the “triple G”, the drug is being promoted online as the next Ozempic.

Healthcare Professionals Express Concerns

However, doctors and chemists have cautions that the sale of what remains an unapproved medication in the UK is a cause for concern and could lead to individuals injecting products of uncertain source.

Some professionals said the demand for retatrutide could be linked to the increasing cost of approved weight loss products such as Mounjaro.

Regulatory Position and Enforcement

Selling the unapproved drug on TikTok or messaging apps is prohibited in the UK, as it is an unapproved drug that cannot be promoted or supplied for human use under the Human Medicines Regulations 2012.

Several content creators try to sidestep the rules by referring to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled substance, but promotion and distribution can still violate pharmaceutical, marketing, and consumer laws, potentially leading to fines, legal action or prison.

Service Reaction and Content Removal

Based on the social media company, the platform has removed violative content and prohibited related keywords and search suggestions. The organization stated it was committed to keeping the platform secure and investing in strengthening compliance measures.

Digital Trading Activities

Research also discovered communities with up to nine thousand members selling retatrutide using the platform's integrated search feature, which operates like a public directory. Typing “retatrutide” immediately brings up channels with thousands of users, populated with images of slimming results, positive testimonials and detailed instructions for preparing or injecting at residence.

Within minutes of entering one group, a seller shared WhatsApp details, where the majority of transactions take place. The seller sent an instruction manual and guaranteed delivery within 48 hours. When asked whether the substance was authentic, one seller said: “You can’t be sure.” Another provided a image of a supposed testing documentation. Not one asked about weight, health issues or previous experience.

Item Details and Pricing

Within these communities, messages display dark colored parcels with Royal Mail labels, stating to include new batches. One message stated: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, mixed at home with sterile water, or pre-filled injectors typically sold at £160 for 20mg. When questioned how long a injector should last, sellers give conflicting answers varying between a several days to “depends on your body”.

Platform Moderation and Security Actions

A spokesperson for the messaging service stated it actively moderated dangerous content on its service including content that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Medical Professional Cautions

“Individuals are administering materials they cannot confirm. Although the science behind retatrutide is valid, these online products may not contain what they claim,” stated Jason Murphy, the director of pharmaceutical services at Chemist4U.

Dr Crystal Wyllie of an online medical service linked the surge in interest to current price rises for approved weight-loss drugs such as Mounjaro. “With prices increasing, patients are using social media. But counterfeit treatments are highly risky. You can’t be certain what’s contained or whether the conditions they were made in was sterile,” she explained.

Her staff has previously encountered patients injured by self-injection from unconfirmed suppliers. “We understand the disappointment, but buying from messaging apps or WhatsApp is taking chances with your well-being,” stated the doctor. “These materials could be contaminated or incorrectly dosed.”

Manufacturer Statement

A representative from the pharmaceutical company said the substance was in phase 3 clinical trials and had not been evaluated or authorized by any government authority globally. “Therefore at this point no one can sell [it] for human use,” they explained, adding that any product “falsely representing itself as a Lilly experimental product not yet authorized … may subject patients to possibly significant medical dangers”.